Article
Cancer biomarker discovery and validation.
1 Jun 2015
Abstract excerpt
With the emergence of genomic profiling technologies and selective molecular targeted therapies, biomarkers play an increasingly important role in the clinical management of cancer patients. Single gene/protein or multi-gene "signature"-based assays have been introduced to measure specific molecular pathway deregulations that guide therapeutic decision-making as predictive biomarkers. Genome-based prognostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
